Vaxart, Inc.
VXRT· OTC
VXRTVaxart, Inc.
Filed Aug 13, 2025 · 10-Q · 44 days after period end · 0001437749-25-026514
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $39.73M | $6.40M | $1.36M | $0.00 |
| Net Income | -$14.99M | -$16.47M | -$22.55M | -$29.43M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Jun 30, 2025 · filed Aug 13, 2025 · 44 d after period end
